James Patterson
Family Medicine · Butler, MONPI 1871579706
Payments from drug & device makers
Across 254 payments — averaging $17.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$845
- Johnson & Johnson$235
- Takeda Pharmaceuticals U.S.A., Inc.$183
- Astellas Pharma US Inc$171
- Otsuka America Pharmaceutical, Inc.$161
- plus $1K from 27 others
What the payments were for
- Food & beverage$4,26595%
- Education$1203%
- Entertainment$922%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 106 | $1,464 |
| AstraZeneca | 40 | $845 |
| Johnson & Johnson | 13 | $235 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $183 |
| Astellas Pharma US Inc | 8 | $171 |
| Otsuka America Pharmaceutical, Inc. | 8 | $161 |
| Vanda Pharmaceuticals Inc. | 4 | $144 |
| Dexcom, Inc. | 7 | $132 |
| Pfizer | 7 | $110 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $96 |
| Lundbeck LLC | 4 | $94 |
| Optos, Inc. | 1 | $92 |
| Axsome Therapeutics, Inc. | 4 | $70 |
| Abbott | 3 | $65 |
| Sunovion Pharmaceuticals Inc. | 4 | $60 |
| Boehringer Ingelheim | 1 | $59 |
| Amgen | 4 | $55 |
| Biocryst US Sales Co., LLC | 3 | $54 |
| Novo Nordisk | 3 | $52 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| GSK | 2 | $37 |
| Novartis | 2 | $33 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $32 |
| Lilly USA, LLC | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Exact Sciences | 1 | $18 |
| Boston Scientific | 1 | $16 |
| Electromed, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Myriad Genetic Laboratories, Inc. | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
| Shire North American Group Inc | 1 | $12 |
How this compares
$4,477 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 161 | $140,472 |
| VraylarCariprazine Hcl | 100 | $134,629 |
| EliquisApixaban | 167 | $105,599 |
| RexultiBrexpiprazole | 47 | $72,388 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 93 | $64,867 |
| FarxigaDapagliflozin Propanediol | 65 | $60,469 |
| OzempicSemaglutide | 42 | $51,361 |
| JanuviaSitagliptin Phosphate | 19 | $32,243 |
| XareltoRivaroxaban | 40 | $30,438 |
| MyrbetriqMirabegron | 60 | $27,389 |
| Fentanyl | 66 | $19,190 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 54 | $17,891 |
| JardianceEmpagliflozin | 18 | $15,607 |
| Varenicline Tartrate | 58 | $15,063 |
| TrulicityDulaglutide | 13 | $14,682 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $37 | $163,374209 claims |
| AbbVieVraylar, Linzess | $1,464 | $147,515119 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Brilinta, Symbicort | $845 | $142,314224 claims |
| PfizerEliquis, Lyrica | $110 | $115,931178 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $161 | $72,38847 claims |
| Novo NordiskOzempic | $52 | $51,36142 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat, Spiriva Respimat | $59 | $31,22549 claims |
| Johnson & JohnsonXarelto | $235 | $30,43840 claims |
| Astellas Pharma US IncMyrbetriq | $171 | $27,38960 claims |
| Lilly USA, LLCTrulicity | $32 | $14,68213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Butler
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.